Real-time enrollment status for this diabetic macular edema (dme) clinical trial
Current Status
Recruiting
Checked: October 5, 2026 at 10:45 PM UTC
| NCT Number | NCT07812090 |
| Recruiting Status | Recruiting |
| Condition | Diabetic Macular Edema (DME) |
| Phase | PHASE2 |
| Target Enrollment | 180 participants |
| Active Locations | 1 sites in the US |
| Sponsor | BioAge Labs, Inc. |
| Last Updated on CT.gov | September 10, 2026 (3 weeks ago) |
As of October 5, 2026: Clinical trial NCT07812090 is currently recruiting participants. This phase2 study for diabetic macular edema (dme) is actively seeking new participants at 1 location across the United States. The study is sponsored by BioAge Labs, Inc.. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT07812090 is actively recruiting participants as of October 5, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 1 location in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT07812090 was last updated 3 weeks ago (September 10, 2026). HelloStudys verifies this status automatically.